上市后化学药品制剂生产场地变更政策解读与常见问题分析

武海军, 周冲, 刘福龙, 陈少鹏

中国药学杂志 ›› 2023, Vol. 58 ›› Issue (1) : 83-86.

PDF(1067 KB)
PDF(1067 KB)
中国药学杂志 ›› 2023, Vol. 58 ›› Issue (1) : 83-86. DOI: 10.11669/cpj.2023.01.012
论著

上市后化学药品制剂生产场地变更政策解读与常见问题分析

  • 武海军1, 周冲1, 刘福龙1, 陈少鹏2
作者信息 +

Problems Analysis and Policy Interpretation in Chemical Preparations Site Change

  • WU Hai-jun1, ZHOU Chong1, LIU Fu-long1, CHEN Shao-peng2
Author information +
文章历史 +

摘要

目的 通过对已上市化药制剂生产场地变更政策解读和常见问题进行分析,为国内制药企业开展相关场地变更研究与质量管理工作提供参考。方法 对近年来出台的系列变更法规、技术指南进行深入解读,对已上市化药制剂生产场地变更中常见问题进行汇总分析。结果 上市药品变更贯穿于药品上市全生命周期,随着科学技术的进步,新原料、新工艺、新分析方法、新设备等新的科技成果都有可能被应用于药品的生产。其中药品生产场地变更是药品上市后变更的重要内容,是上市药品质量风险管理最具挑战性的一部分。结论 药品上市许可持有人作为药品上市后生产场地变更管理的责任主体,应当主动按照相关法规、指导原则的要求,开展药品上市后研究,实现全生命周期管理。

Abstract

OBJECTIVE To provide reference for domestic pharmaceutical enterprises to carry out relevantchange research and quality management, based on analyzing the problems and interpretating the policy in the process of specific production site change. METHODS This paper deeply interprets a series of change technical guidelines issued in recent years, and summarized the common problems in the change of chemical preparations site. RESULTS The process change of listed drugs runs through the whole life cycle of drug listing. With the progress of science and technology, new scientific and technological achievements such as new raw materials, new processes, new analytical methods and new equipment may be applied to drug production. Among them, the change of drug manufacturing site is an important part of the change in the listing of drugs, which is the most challenging part of the quality risk management of listed drugs.CONCLUSION As the main body of drug manufacturing site change researches, marketing authorization holders should carry out drug production change research, complying with the requirement of series change technical guidelines, to realize the management through the whole life cycle of drug listing.

关键词

制剂 / 变更管理 / 生产场地变更 / 技术指南

Key words

preparation / change management / production site change / technical guideline

引用本文

导出引用
武海军, 周冲, 刘福龙, 陈少鹏. 上市后化学药品制剂生产场地变更政策解读与常见问题分析[J]. 中国药学杂志, 2023, 58(1): 83-86 https://doi.org/10.11669/cpj.2023.01.012
WU Hai-jun, ZHOU Chong, LIU Fu-long, CHEN Shao-peng. Problems Analysis and Policy Interpretation in Chemical Preparations Site Change[J]. Chinese Pharmaceutical Journal, 2023, 58(1): 83-86 https://doi.org/10.11669/cpj.2023.01.012
中图分类号: R95   

参考文献

[1] LI C, CHEN G L. Analysis of China regulatory strategy on post-approval changes of pharmaceutical products[J]. Chin New Drugs J(中国新药杂志), 2022, 31(2):155-159.
[2] LI S, ZHANG J C. Management of drug production process changegs based on pharmaceutical quality system[J]. Chin Pharm J(中国药学杂志), 2015, 50(16):1462-1464.
[3] WANG S H, LU X J, CHEN A P, et al. Interpretation of changes to preparation production process, batch and packaging materials according to technical guideline for making post approval changes to chemical drug products (trial implementation) [J]. China Food Drug Adm Mag(中国食品药品监管), 2022, 08(223):46-51.
[4] WANG X J, WANG D X, ZHU Q, et al. The focus of the quality research Oil quality comparison of drugtechnology transfer[J]. China Med Pharm(中国医药科学), 2016, 6(14):221-223.
[5] XIE J Z, ZHOU C,YIN N N, et al. Discuss on the common probiems of drug technology transfer in Shandong Province[J]. J Pharm Res(药学研究), 2018, 37(9):552-554.
[6] WANG S H, XU Z Y. Interpretation of changes to excipients in drug product formulation according to technical guideline for making post approval changes to chemical drug products (trial implementation)[J]. China Food Drug Adm Mag(中国食品药品监管), 2022, 08(223):38-42.
[7] ZHOU C, DONG A M, LIU J T. Problem analysis of the chemical drug quality research of entrusted productionunder MAH system in Shandong Province [J]. Food Drug(食品与药品), 2020, 22(4):290-293.
[8] WANG L J, ZHAI L W. Enlightenment of ICH Q12 to the management of post-approval CMC changes [J]. Chin Pharm Aff(中国药事), 2021, 35(11):1207-1211.
[9] LI S, MEI N, CHEN G L. Analysis of some characteristics and managementof drug changes in the whole life cycle [J]. Chin New Drugs J(中国新药杂志), 2022, 31(2):165-171.
[10] LI X Y, YANG Y. Research on american regulations of drug manufacturing site changes[J]. Chin Pharm J(中国药学杂志), 2016, 51(8):671-677.
PDF(1067 KB)

Accesses

Citation

Detail

段落导航
相关文章

/